Treatment News : Designer Enzyme to Fight HIV Shows Promise - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2007

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 29, 2007

Designer Enzyme to Fight HIV Shows Promise

by Tim Horn

Scientists in Germany have constructed a custom enzyme that reverses the process by which HIV inserts its genetic material into a CD4 cell's DNA, suggesting that treatment with similar enzymes could potentially rid infected cells of the virus. According to laboratory study results published in Science, the mutated enzyme—called Tre recombinase—was able to snip HIV DNA out of the chromosomes of cultured human tissue. 

While one widespread media report has gone so far as to bill the findings as a "potential cure for HIV," the authors of the study—led by Indrani Sarkar, PhD, of the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden—remain much more reserved. Curing any infection using this technique, they caution, would first require mastering one of HIV's sneakiest tricks: its ability to hide from the immune system by laying dormant for months or years in host cells.

HIV infects CD4 cells by first using the enzyme reverse transcriptase to convert its RNA into double-stranded DNA and then, using the enzyme integrase, to insert the DNA into the cell's genome. Researchers have speculated that they could reverse this process with bacterial DNA-cutting enzymes they have adapted for adding and subtracting genes from mice and other multi-celled organisms.

To take that step, Dr. Sarkar's group began with the bacterial enzyme Cre recombinase, which exchanges any two pieces of DNA flanked on either end by a certain pattern of nucleotides (DNA subunits) known as loxP.

HIV does not naturally contain loxP sites, so the team created a hybrid of the two DNA molecules, which they used to select a series of mutated Cre enzymes that were increasingly able to recognize the combined DNA. The final enzyme, Tre, removed all traces of HIV from cultured human cervical cells after about three months.

According to an editorial accompanying the report, authored by Alan Engelman, PhD, a molecular virologist at the Dana-Farber Institute in Boston, the work of Dr. Sarkar's team is the first demonstration of actual removal of the integrated virus from cells.  The results are promising, he says, but researchers have to make sure the slow-acting Tre enzyme works on real-world strains of HIV and figure out how to safely and precisely administer it in gene form to give it time to snip.

Ideally, Engelman writes, researchers would like to find a way to send Tre enzymes into the small number of CD4 cells that carry the virus without producing new viral particles, which allows HIV to hide from both antiretroviral drugs and the immune system.

Sources:

Engelman A. AIDS/HIV: a reversal of fortune in HIV-1 integration. Science 316(5833):1855, 2007.

Sarkar I, Hauber I, Hauber J, et al. HIV-1 proviral DNA excision using an evolved recombinase. Science 316(5833):1912, 2007.


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    RyGuy00
    New York
    New York


    max38man
    Chicago
    Illinois


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.